BC Week In Review | May 26, 2014
Clinical News

Access AccuTnl+3 troponin I assay regulatory update

The U.K.'s NICE issued draft guidance recommending the Elecsys Troponin T high-sensitive assay from Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland) and the Architect Stat High Sensitive Troponin-I assay from Abbott Laboratories (NYSE:ABT, Abbott Park, Ill.) for...
BC Week In Review | May 26, 2014
Clinical News

Elecsys Troponin T high-sensitive assay regulatory update

The U.K.'s NICE issued draft guidance recommending the Elecsys Troponin T high-sensitive assay from Roche and the Architect Stat High Sensitive Troponin-I assay from Abbott Laboratories (NYSE:ABT, Abbott Park, Ill.) for the early rule out...
BC Week In Review | May 26, 2014
Clinical News

Architect Stat High Sensitive Troponin-I Assay regulatory update

The U.K.'s NICE issued draft guidance recommending the Elecsys Troponin T high-sensitive assay from Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland) and the Architect Stat High Sensitive Troponin-I assay from Abbott for the early rule out of...
BC Week In Review | Oct 7, 2013
Clinical News

Access AccuTnl+3 troponin I assay regulatory update

Danaher's Beckman Coulter Inc. subsidiary said FDA granted 510(k) clearance for its Access AccuTnl+3 troponin I assay for use on its UniCel DxI series of immunoassay systems to determine levels of cardiac troponin I in...
BC Week In Review | Jun 24, 2013
Clinical News

Access AccuTnl+3 troponin I assay regulatory update

Danaher's Beckman Coulter Inc. subsidiary said FDA granted 510(k) clearance for its Access AccuTnl+3 troponin I assay for use on its Access 2 immunoassay system to determine levels of cardiac troponin I in human serum...
Items per page:
1 - 5 of 5